New generation of cancer stem cells inhibitors in non-small cell lung cancer.

被引：0
|
作者：
Labrador, Hector Amado
Aguilar-Gallardo, Cristobal
Herreros-Pomares, Alejandro
Munera-Maravilla, Ester
Calabuig-Farinas, Silvia
Escorihuela, Eva
Murga, Juan
Jantus-Lewintre, Eloisa
Camps, Carlos
机构：
[1] Lab Oncol Mol, FIHGUV, Fundacion Carolina, BBVA, Valencia, Spain
[2] CIBERONC, Valencia, Spain
[3] Centro Investig Energet, Medioambient Tecnolog, CIEMAT, Oncol Mol, Madrid, Spain
[4] Univ Valencia, Dept Patol, Valencia, Spain
[5] Univ Jaume 1, Dep Quim Inorgan Organ, Castellon de La Plana, Spain
[6] Univ Politecn Valencia, Dept Biotecnol, Valencia, Spain
[7] Univ Valencia, Dept Med, Valencia, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20545
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Novel biomarkers of non-small cell lung cancer (NSCLC) stem cells
    Karimi-Busheri, Feridoun
    Zadorozhny, Victoria
    Shawler, Daniel L.
    Fakhrai, Habib
    CANCER RESEARCH, 2011, 71
  • [22] Immunological markers of outcome of non-small cell lung cancer.
    Potter, DA
    Amin, C
    Mohiuddin, A
    Badve, S
    Davidson, D
    Kesler, K
    Hanna, N
    Edenberg, H
    Einhorn, L
    Mitra, R
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 678S - 678S
  • [23] LungTS: A new gene expression signature for prediction of response to checkpoint inhibitors in non-small cell lung cancer.
    De Marchi, Pedro
    Leal, Leticia Ferro
    Da Silva, Luciane Sussuchi
    Cavagna, Rodrigo De Oliveira
    Ferreira Da Silva, Flavio Augusto
    Da Silva, Vinicius Duval
    Da Silva, Eduardo Ca
    Saito, Augusto Obuti
    Aguado, Cristina
    Bracht, Jill
    Gonzalez-Cao, Maria
    Gimenez-Capitan, Ana
    Pedraz, Carlos
    Silva Sa, Daniella Dias
    Molina Vila, Miguel Angel
    Cordeiro De Lima, Vladmir Claudio
    Reis, Rui Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Embryonic stem cells against non-small cell lung cancer in vivo
    杜贾军
    China Medical Abstracts(Surgery), 2011, 20 (03) : 161 - 161
  • [25] Research status and controversy on non-small cell lung cancer stem cells
    Wang, Jin
    Chen, Yunqing
    Wang, Chengqin
    Ren, Keyu
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2024,
  • [26] Immune therapy of non-small cell lung cancer. The future
    Bobbio, Antonio
    Alifano, Marco
    PHARMACOLOGICAL RESEARCH, 2015, 99 : 217 - 222
  • [27] Association of brain metastasis in non-small cell lung cancer.
    Zhao, Yu
    Guo, Huiqin
    Lu, Jiangyang
    Christiani, David C.
    Lin, Xihong
    Wang, Zhaoxi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Second generation ALK inhibitors in non-small cell lung cancer: Systemic review
    Viala, Marie
    Brosseau, Solenn
    Planchard, David
    Besse, Benjamin
    Soria, Jean-Charles
    BULLETIN DU CANCER, 2015, 102 (04) : 381 - 389
  • [29] Constitutive kinase activity and survival of non-small cell lung cancer cells: new molecular determinants of therapeutic resistance in lung cancer.
    Brognard, J
    Clark, A
    Oppoliner, A
    Dennis, P
    CLINICAL CANCER RESEARCH, 1999, 5 : 3801S - 3801S
  • [30] Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer
    Blackhall, FH
    Shepherd, FA
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (05) : 1121 - +
12345